Enacting this Bill into law could be a game-changer in that it will expressly authorize CBD in food and as a dietary supplement; however, passage in the Senate is far from a foregone conclusion.
The FDA is poised to be the primary regulatory body governing and setting policy for consumer sales of CBD in the USA. The “wild card” is what, if anything, it will do about products containing hemp extract with CBD.
As an advisory board member and legal author for the American Journal of Endocannabinoid Medicine, I am pleased to offer a copy of the most recent edition in PDF form at the bottom of this blog. Immediately below is my article.
I was recently asked by my friends at Darling Hemp to participate in a video they created to highlight some of the most important issues that the Rule raises.
In this article I will discuss the Rule’s impact on hemp that was grown and harvested in 2019, much of which is currently on the market.
Kight Law is proud to announce that it is included in the US News and Best Lawyers list of “Best Law Firms” of 2020.
As the cannabis industry matures, insurance is becoming a major factor in its growth and normalization. In many respects, the development and availability of insurance products signals a new phase in the industry.
Cannabis helped me through chemotherapy and I resolved at that time to advocate professionally for its legalization. Although it took some time to make the shift in my law practice, the cannabis law seed took root as I recovered from cancer.
The International Cannabis Law Bar Association held a conference in NYC on a wide array of cannabis law topics by some of the most active cannabis law attorneys in the country, including Kight Law attorneys Rod Kight and Kamran Aryah.
WLOS covered the emerging smokable hemp issue. I am happy to have been interviewed for the story.